Five-year, Multicenter Safety Study of Fixed-combination Latanoprost/Timolol (Xalacom) for Open-angle Glaucoma and Ocular Hypertension
Journal of Glaucoma, 04/11/2011Alm A et al.
After 5 years, more than 70% of participants treated with fixed–combination latanoprost/timolol had no increased iris pigmentation. The fixed combination is safe and well tolerated for long–term treatment in patients with open–angle glaucoma or ocular hypertension.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.